Mini heart pump trial halted, but shows promise for advanced heart failure

NCT ID NCT01831544

Terminated Disease control Sponsor: Medtronic Cardiac Rhythm and Heart Failure Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 25 times

Summary

This study tested a small heart pump called the HeartWare MVAD in 11 people with severe heart failure. The goal was to see if the device is safe and helps patients live longer. The trial was stopped early, but it looked at survival rates at 6 and 24 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Duesseldorf University Hospital

Düsseldorf, 40225, Germany
Freeman Hospital

Newcastle upon Tyne, NE77DN, United Kingdom
German Heart Institute Berlin DHZB

Berlin, 13353, Germany
Hannover Medical School MHH

Hanover, 30625, Germany
Hospitalier Pitié-Salpétrière

Paris, 75013, France
Medical University AKH Vienna

Vienna, 1090, Austria
Papworth Hospital NHS Foundation

Papworth Everard, CB233RE, United Kingdom
St. Vincents Hospital

Darlinghurst, 2010, Australia
The Heart and Diabetes Center NRW

Bad Oeynhausen, 32545, Germany
Uniklinik Hamburg Eppendorf (UKE)

Hamburg, 20245, Germany
University of Leipzig Heart Center

Leipzig, 04289, Germany

Conditions

Explore the condition pages connected to this study.

HEART FAILURE